Dr. Mary Elizabeth Fleischli, MD

Dr. Fleischli practices at Advanced Dermasurgery Associates in Dallas, Texas.

Dr. Fleischli's NPI, 1245228063, was assigned on October 6, 2005. Dr. Fleischli graduated from Harvard Medical School in 1993. Dr. Fleischli holds Texas license K3186.

Dr. Fleischli's primary practice is Advanced Dermasurgery Associates, at 10703 Preston Rd, Dallas, TX 75230 in Dallas County. The practice phone is (214) 987-3376.

Dr. Fleischli's primary practice is Advanced Dermasurgery Associates in Dallas, Texas. Dr. Fleischli is also affiliated with William P. Clements Jr. University Hospital. The medical group on file is Dallas Associated Dermatologists. Dmand AI also links Dr. Fleischli to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fleischli practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Fleischli's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Fleischli is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Fleischli's licenses on file in 3 states: Texas, Florida and Utah.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, facial skin infection and hives among the conditions Dr. Fleischli treats.

CMS data shows 3,608 Medicare services from Dr. Fleischli across 21 procedure codes in 2024, for 687 Medicare patients. Medicare paid $168,221 for them. Every service was in an office.

CMS counts 687 Medicare patients who saw Dr. Fleischli in 2024. The largest group is 65 to 74, with 393 patients. 75% of them have high cholesterol, and 62% have high blood pressure. Their average risk score is 0.80, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Fleischli's median patient age at 58, with 69% women.

In 2024, Dr. Fleischli wrote 647 Medicare Part D claims for 363 patients. 99% of them were for generic drugs. CMS names the drug for 537 of them, across 10 drugs with 11 or more claims each, at $11,740 in total drug cost. In 2023, CMS named 521 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Fleischli for performance year 2024, reported as part of a group. Dr. Fleischli accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,313 procedures of removal of skin lesions by Dr. Fleischli, more than 95% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Fleischli, published from 2017 to 2019. The most frequent topics are Black or African American, Racism and Affect. Dr. Fleischli's most frequent co-author is Amit G. Pandya, MD.

CMS Open Payments shows 1,703 general payments to Dr. Fleischli from 48 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 74% of the total. Allergan Inc. paid the most, $87,375.

Dmand AI lists 1 award for Dr. Fleischli.

Dr. Fleischli graduated from Harvard Medical School in 1993. Dr. Fleischli is a member of AAD.

Dr. Fleischli is in network with 23 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.